The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Platinum), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
Welcome to The Non-Hodgkin Lymphoma (NHL) Channel
VJHemOnc shares with you the most impactful updates and insights in the field of non-Hodgkin lymphoma (NHL), directly from top researchers from around the world. As well as video interviews on key talks and abstracts from major international congresses, you can explore our ever-growing selection of podcasts, roundtable discussions and more to stay up-to-date on critical updates in the NHL field.
The Non-Hodgkin Lymphoma Channel brings you updates from key clinical trials of CAR-T & cellular therapies, immunotherapies and novel combination regimens for the treatment of NHL. Findings from studies of real-world data and research identifying novel biomarkers are presented, in addition to commentary on the impact of novel therapies and considerations for integration into routine clinical practice.
Sorry, no posts matched your criteria.
The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Platinum), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
Platinum Supporter
Gold Supporter
Silver Supporter
Bronze Supporter
If you are interested in becoming a supporter of The Lymphoma Channel, please contact us.
